چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| Objectives: Substituting antidotes with longer half-lives may decrease the danger of unobserved respiratory depression in opioid overdose. The present triple-blind controlled trial aimed to compare two different doses of naltrexone (i.e., 50 vs. 100 mg) in the maintenance therapy regarding methadone-overdosed in opioid-naïve patients. Materials and Methods: Seventy opioid-naïve methadone-intoxicated patients with a mean age of 26 ± 9 years were prospectively included in this study and were treated with naloxone. They were then consecutively assigned to A or B groups (including 35 patients each) receiving 100- and 50-mg naltrexone capsules, respectively. The patients were followed for 48 hours in the hospital and re-evaluated by a phone call follow-up after discharge. Finally, they were compared regarding re-development of the toxicity signs and symptoms, a need for re-administration of naloxone, and the final outcome. Results: Based on the results, only diastolic blood pressure, serum bicarbonate, and base excess were significantly different between the groups. During hospitalization, one patient in group A experienced apnea while none of the patients in group B had such an experience (P > 0.05). In addition, in follow-up evaluations and after the hospital discharge, the mean venous blood gas (VBG) parameters were found to be identical between both groups. Hospitalization period was similar (all P values were greater than 0.05). Conclusions: In general, 2 different 50- and 100-mg regimens of naltrexone have the same efficacy in preventing the apnea and respiratory depression in methadone-intoxicated opioid-naïve patients. However, the 50-mg dose is the superior regimen recommended in this respect. |
| نویسنده | نفر چندم مقاله |
|---|---|
| علی استادی | اول |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| pdf_CJMB_230.pdf | 1397/11/10 | 208357 | دانلود |
